Shoppers Often Miss Best Drugs for Period Cramps

Many women shopping for period pain relief are buying medicines that work less well for cramps, according to supermarket sales data that has pushed doctors and pharmacists to restate a fairly basic point: for most period pain, anti-inflammatory drugs beat simple painkillers.

The mismatch is practical, not academic. If shoppers with dysmenorrhoea are picking up paracetamol instead of ibuprofen or another non-steroidal anti-inflammatory drug, they're more likely to get partial relief at best, and sometimes very little.

That matters because period pain is common, disruptive and, too often, brushed off. From a clinical standpoint, the logic here is straightforward. Menstrual cramps are driven by prostaglandins, chemical messengers that trigger uterine contractions. NSAIDs such as ibuprofen reduce prostaglandin production; paracetamol does not. That's why the first group tends to work better for cramping pain.

Here's the thing: sales data can show what people buy, not why they buy it, whether they used it correctly, or whether it worked. That's a real limit. It doesn't tell us the age of the buyer, the severity of symptoms, whether they had heavy bleeding, whether they were avoiding NSAIDs because of asthma, ulcers or kidney disease, or whether they were already taking another medicine that made ibuprofen a bad idea.

Still, the broad medical point holds up. Clinical guidance has long treated NSAIDs as a first-line option for primary dysmenorrhoea, and that isn't based on marketing copy. It's based on comparative evidence accumulated over years, including studies indexed by PubMed and guidance reflected by public health bodies. The NHS, for example, advises that ibuprofen or other anti-inflammatory painkillers can help period pain, while also spelling out who shouldn't take them.

For ordinary period cramps, buying paracetamol first is often buying the weaker tool.

What the shelf gets wrong

Over-the-counter medicine aisles are not designed for pathophysiology. They're designed for quick decisions, bright packaging and a shopper who wants to be done in 40 seconds. So people often choose by brand familiarity, price, or whatever says "pain relief" in the largest font. The uterus, needless to say, doesn't care about branding.

And there's an old public-health problem sitting underneath this. Many people know paracetamol as the default pain medicine for headaches, fever and general aches. It's widely used, cheap and familiar. That makes it an easy grab for menstrual pain too, even though cramps are a more specific kind of pain with a more specific best treatment.

One clean sentence of skepticism is warranted here: supermarket receipts are not a randomized controlled trial.

But they can still expose a behavior gap. If the data consistently show women buying products that clinicians view as second-best for cramps, then the problem may be the way pain relief is explained, packaged and displayed. It may also reflect caution. Some shoppers avoid ibuprofen because they've been told to steer clear during pregnancy, because they have stomach issues, or because they've had side effects before. Others may not know what an anti-inflammatory drug even is.

That educational gap is hardly confined to periods. We see the same thing in obesity medicines, where access and understanding often split apart; our coverage of the UK decision on a daily Wegovy pill option touched on how drug categories can race ahead of public comprehension. Medicine isn't just about what exists. It's about whether people know which box to pick up, and when not to.

The medical caveat nobody should skip

NSAIDs are usually the better option for period cramps, but "usually" is doing honest work here. These drugs are not appropriate for everyone. People with a history of stomach ulcers, gastrointestinal bleeding, certain kidney problems, NSAID-sensitive asthma, or those taking particular blood thinners may need to avoid them or use them only after medical advice. That is not fussy fine print. It's the difference between useful self-care and a bad complication.

There is another wrinkle. Severe period pain, pain that suddenly worsens, pain with very heavy bleeding, pain between periods, or pain that doesn't respond to standard treatment can point to secondary causes such as endometriosis or fibroids. Self-treating month after month without asking why the pain is so intense is a mistake. Period pain can be common and still deserve investigation.

That's one reason I bristle when these stories are framed as simple consumer error. Sometimes the shelf is confusing. Sometimes the label is vague. And sometimes women have been taught, over years, to treat period pain as a private inconvenience rather than a symptom worth understanding. Dry observation, but true.

The evidence base for NSAIDs in primary dysmenorrhoea is not new, and it has been replicated. Peer review doesn't make every study right, and it doesn't rescue a weak design. What it does mean is that experts have at least examined the methods, the analysis and the claims before publication. That is a world away from anecdote and a little better than shelf data.

Why this story lands now

It lands because women are doing more of their own care in pharmacies and supermarkets, often under pressure and without much time. It also lands because the internet is full of health advice of wildly variable quality. Some of it is decent. Some of it belongs in the bin. The result: people arrive at the medicine aisle carrying fragments of truth, old family habits and half-remembered warnings.

Clinicians have their own share of blame. We tend to explain what to take, but not always why one drug class works better than another. When patients understand mechanism, adherence improves. That's one reason many doctors are leaning on digital tools for fast evidence checks, as we reported in our piece on OpenEvidence in clinical practice. Patients deserve the same clarity, just in plain English.

There is also a broader dignity issue here. Women's pain is still too easy to minimize, whether we're talking about cramps, menopause symptoms or dementia care for older women. The cultural habit of shrugging at suffering shows up everywhere, including in our coverage of readers calling for dignity in dementia. Different condition, same old blind spot.

For now, the takeaway is simple enough to be useful. If the pain is straightforward menstrual cramping and you can safely take them, anti-inflammatory medicines are generally the better first choice than paracetamol. If you can't take NSAIDs, or if the pain is severe, persistent or unusual, that is the point to ask a pharmacist or doctor rather than keep experimenting in aisle seven.

What to watch next is whether retailers, pharmacists or the NHS respond with clearer in-store advice and updated patient information on period pain treatment, and whether any fuller data are released showing exactly which products women were buying and in what proportions.